Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are l

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Artificial Life (OTCMKTS:ALIF - Get Free Report) and Dolby Laboratories (NYSE: DLB - Get Free Report

Kevin Yeaman to Retire from Dolby  Marc Whitten Named President, Chief Executive Officer and Directo

Cinemo, a global leader and one-stop-shop provider for fully integrated, innovative multi-device in-

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies

Assenagon Asset Management S.A. increased its stake in shares of Dolby Laboratories (NYSE: DLB) by 8

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Innovation Passport award designed to support accelerated time to market and help expedite patient a

Dolby targets a sharp fiscal Q4 rebound as content deals, auto Atmos growth and licensing gains face

Dolby's discounted valuation and $756 million cash balance support its long-term case as premium for

Amazon surges 15% on an AWS blowout while Apple sheds nearly $475 billion in value. Yields sit at cy

Dolby beat on earnings but missed on sales last night. Both earnings and sales declined year over ye

U.S. stocks mixed, Nasdaq up 50 pts. AXT Inc (NASDAQ: AXTI) rose 25.3% on strong Q2 results. Other g

DLB beat Q3 earnings estimates despite lower revenue, then forecast strong Q4 growth backed by video

Dolby Laboratories NYSE: DLB reported third-quarter fiscal 2026 revenue of $305 million, within its

Dolby Laboratories (DLB) came out with quarterly earnings of $0.69 per share, beating the Zacks Cons

Although the revenue and EPS for Dolby Laboratories (DLB) give a sense of how its business performed

Dolby Laboratories, Inc. (DLB) Q3 2026 Earnings Call Transcript

Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.

Dolby Laboratories (NYSE:DLB) lowers FY2026 Adj EPS guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.3

Dolby Laboratories (NYSE:DLB) is looking for Q4 Adj EPS of $1.13-$1.28 vs $1.20 analyst estimate. se

Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.69 per share which beat the analyst

SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the

For the second quarter of 2026, Aristotle Capital's Global Equity WM Composite posted a total return

Dolby Laboratories is now undervalued after a 50%+ decline from its all-time high, trading at 18.7x

SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immer

BOSTON, July 14, 2026 (GLOBE NEWSWIRE) -- CervoMed Announces New Clinical, Plasma Biomarker and Imag

Find bargains in oversold IT stocks with RSI values below 30: Fabrinet (NYSE: FN), Dolby Laboratorie

U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on

Dolby Laboratories (NYSE:DLB) is looking for Q3 Adj EPS of $0.56-$0.71 vs $0.98 analyst estimate. se

Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.

Dolby Laboratories (NYSE:DLB) affirms FY2026 Adj EPS guidance from $4.30-$4.45 to $4.30-$4.45 vs $4.

Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.37 per share which beat the analyst

Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:DLB) with a Outperfo

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain

Dolby Laboratories (NYSE:DLB) raises FY2026 GAAP EPS guidance from $2.61-$2.76 to $2.71-$2.86 vs $2.

Dolby Laboratories (NYSE:DLB) raises FY2026 Adj EPS guidance from $4.19-$4.34 to $4.30-$4.45 vs $4.2

Dolby Laboratories (NYSE:DLB) is looking for Q2 Adj EPS of $1.29-$1.44 vs $1.37 analyst estimate. se

Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.06 per share which beat the analyst

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain

https://aws.amazon.com/blogs/media/from-flat-to-full-immersion-the-aws-path-to-dolby-vision-and-dolb

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers t